Mindpax GmbH

Mindpax is an early-stage digital medicine company that is building a comprehensive digital disease management system for severe psychiatric diseases using new digital biomarkers, digital phenotyping and long-term monitoring of patients. Key opinion leaders in European and US psychiatry support the long-term monitoring of mental health patients as the only way to understand the diseases better. Mindpax is unique in collecting highly annotated clinical data in clinical trials (often being the largest and longest with such focus). The doctor's decision support & patient's empowerment system informs the doctor/medical staff in case there is an increased probability of disease relapse in order to do early intervention. Based on literature evidence, early intervention shortens the length of hospitalization and can avoid hospitalization altogether.